← Leaderboards
Gerard A Cangelosi
Seattle Biomedical Research Institute
$11,224,366
Attributed
$12,964,989
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,964,989 · 12
By mechanism
R01$5,925,267 · 4
U01$4,675,389 · 1
R21$2,134,103 · 5
R41$220,230 · 1
R13$10,000 · 1
Top collaborators
- Robert William Doebler4 shared
- Masa Narita4 shared
- Angelika Niemz4 shared
- Brenda Elaine Jones2 shared
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingCellsBaseTuberculosisMycobacterium TuberculosisDiagnosisSputumPerformanceLaboratoriesPathogenComplexPulmonary TuberculosisDiagnosticDetectionSensitivity And SpecificityPoint Of CareValidationPolymerase Chain ReactionGrantDesignSurfacePoint-Of-Care DiagnosticsTransmission ProcessResearch Personnel
Grant awards (34)
High-sensitivity tongue swab testing for tuberculosis$155,500
R21 · FY2025 · AI · contact PI
High-sensitivity tongue swab testing for tuberculosis$272,125
R21 · FY2024 · AI · contact PI
Non-invasive diagnosis of adult pulmonary tuberculosis$347,751
R01 · FY2022 · AI · contact PI
Non-invasive diagnosis of adult pulmonary tuberculosis$315,387
R01 · FY2021 · AI · contact PI
Non-invasive diagnosis of adult pulmonary tuberculosis$320,490
R01 · FY2020 · AI · contact PI
Molecular confirmation of tuberculosis treatment$150,905
R21 · FY2020 · AI · contact PI
Non-invasive diagnosis of adult pulmonary tuberculosis$346,207
R01 · FY2019 · AI · contact PI
Molecular confirmation of tuberculosis treatment$228,926
R21 · FY2019 · AI · contact PI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$538,394
R01 · FY2017 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$541,354
R01 · FY2016 · AI
Tuberculosis case finding by oral swab PCR$164,063
R21 · FY2016 · AI · contact PI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$555,804
R01 · FY2015 · AI
Ultra-Sensitive Diagnosis of AIDS-Related Tuberculosis$220,230
R41 · FY2015 · AI · contact PI
Tuberculosis case finding by oral swab PCR$210,500
R21 · FY2015 · AI · contact PI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$607,711
R01 · FY2014 · AI
Accelerated molecular probe pipeline$683,601
U01 · FY2013 · AI · contact PI
Point-of-care concentration and detection of pathogen antigens in samples$502,688
R01 · FY2013 · AI · contact PI
Accelerated molecular probe pipeline$581,394
U01 · FY2012 · AI · contact PI
Accelerated molecular probe pipeline$407,963
U01 · FY2012 · AI · contact PI
In situ analysis of bacterial biosynthetic activity in subgingival plaque$196,550
R21 · FY2012 · DE · contact PI
Point-of-care concentration and detection of pathogen antigens in samples$82,218
R01 · FY2012 · AI · contact PI
In situ analysis of bacterial biosynthetic activity in subgingival plaque$17,404
R21 · FY2012 · DE · contact PI
Accelerated molecular probe pipeline$951,168
U01 · FY2011 · AI · contact PI
Point-of-care concentration and detection of pathogen antigens in samples$638,430
R01 · FY2011 · AI · contact PI
In situ analysis of bacterial biosynthetic activity in subgingival plaque$281,254
R21 · FY2011 · DE · contact PI
Accelerated molecular probe pipeline$971,923
U01 · FY2010 · AI · contact PI
Accelerated molecular probe pipeline$1,079,340
U01 · FY2009 · AI · contact PI
Genetic Analysis of Mycobacterial Biofilm Formation$205,741
R21 · FY2005 · AI
Genetic Analysis of Mycobacterial Biofilm Formation$251,135
R21 · FY2004 · AI
Environmental Microorganisms as Human Pathogens$10,000
R13 · FY2004 · AI
MULTIDRUG RESISTANT MORPHOTYPIC VARIANTS OF M. AVIUM$291,498
R01 · FY2003 · AI
MULTIDRUG RESISTANT MORPHOTYPIC VARIANTS OF M. AVIUM$293,008
R01 · FY2002 · AI
MULTIDRUG RESISTANT MORPHOTYPIC VARIANTS OF M. AVIUM$271,292
R01 · FY2001 · AI
MULTIDRUG RESISTANT MORPHOTYPIC VARIANTS OF M. AVIUM$273,035
R01 · FY2000 · AI